Abstract
Objective
The aim of this study was to investigate the chemokine expression profiles in gingival crevicular fluid (GCF) and serum in patients with advanced chronic periodontitis and to assess the impact of smoking on local and systemic levels of chemokines.
Materials and methods
Thirty patients with chronic periodontitis (CP; 20 smokers and 10 non-smokers) and 20 periodontally healthy subjects (10 smokers and 10 non-smokers) were recruited. Clinical parameters included the plaque index (PI), gingival index (GI), and bleeding on probing (BOP). Macrophage inflammatory protein-1 alpha (MIP-1α), macrophage inflammatory protein-1 beta (MIP-1β), monocyte chemoattractant protein-1 (MCP-1), and regulated on activation normal T cell expressed and secreted chemokine (RANTES) were measured in gingival crevicular fluid (GCF) and serum using a multiplex immunoassay.
Results
MIP-1α levels were significantly lower (10.15 ± 1.48; p = 0.039) while MIP-1β levels were significantly higher (42.05 ± 8.21; p = 0.005) in sera from non-smoker patients with CP compared to non-smoker healthy subjects. MCP-1 concentration in sera was significantly higher in smoker periodontitis patients (8.89 ± 1.65) compared to non-smoker patients with periodontitis (8.14 ± 0.97; p = 0.004). MIP-1α and RANTES were significantly higher in GCF of the patients with CP (p = 0.001) while there were no statistically significant correlations between the GCF levels of these analytes and the smoking status.
Conclusion
Periodontal inflammation increases the chemokine concentrations in the GCF while smoking suppresses chemokine levels in serum suggesting that different local and systemic mechanisms are involved during the response to periodontitis in smokers.
Clinical relevance
Understanding the local and systemic chemokine responses in smokers will enable the development of biologically-based treatment methods for chronic periodontitis.
Similar content being viewed by others
Notes
Periopaper, Oraflow Inc. New York, USA
Venoject Terumo Europe N.V.3001 Leuven, Belgium
Heraeus Labofuge 300, Kendro Laboratory Products, Osterrode, Germany
Luminex 100 MiraiBio, Alameda, CA, USA
Procarta® Cytokine Assay Kit, Panomics Inc. Fremont, USA
References
Garlet GP, Avila-Campos MJ, Milanezi CM, Ferreira BR, Silva JS (2005) Actinobacillus actinomycetemcomitans-induced periodontal disease in mice: patterns of cytokine, chemokine, and chemokine receptor expression and leukocyte migration. Microbes Infect 7(4):738–747. doi:10.1016/j.micinf.2005.01.012
Silva TA, Garlet GP, Fukada SY, Silva JS, Cunha FQ (2007) Chemokines in oral inflammatory diseases: apical periodontitis and periodontal disease. J Dent Res 86(4):306–319
Graves D (2008) Cytokines that promote periodontal tissue destruction. J Periodontol 79(8 Suppl):1585–1591. doi:10.1902/jop.2008.080183
Bachmann MF, Kopf M, Marsland BJ (2006) Chemokines: more than just road signs. Nat Rev Immunol 6(2):159–164. doi:10.1038/nri1776
Baggiolini M (1998) Chemokines and leukocyte traffic. Nature 392(6676):565–568. doi:10.1038/33340
Kabashima H, Yoneda M, Nagata K, Hirofuji T, Maeda K (2002) The presence of chemokine (MCP-1, MIP-1alpha, MIP-1beta, IP-10, RANTES)-positive cells and chemokine receptor (CCR5, CXCR3)-positive cells in inflamed human gingival tissues. Cytokine 20(2):70–77
Jiang Y, Graves DT (1999) Periodontal pathogens stimulate CC-chemokine production by mononuclear and bone-derived cells. J Periodontol 70(12):1472–1478. doi:10.1902/jop.1999.70.12.1472
Fleetwood AJ, Dinh H, Cook AD, Hertzog PJ, Hamilton JA (2009) GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on type I interferon signaling. J Leukoc Biol 86(2):411–421. doi:10.1189/jlb.1108702
Niu J, Kolattukudy PE (2009) Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications. Clin Sci (Lond) 117(3):95–109. doi:10.1042/CS20080581
Koch AE, Kunkel SL, Harlow LA, Johnson B, Evanoff HL, Haines GK, Burdick MD, Pope RM, Strieter RM (1992) Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J Clin Invest 90(3):772–779. doi:10.1172/JCI115950
Graves DT (1999) The potential role of chemokines and inflammatory cytokines in periodontal disease progression. Clin Infect Dis 28(3):482–490. doi:10.1086/515178
Emingil G, Atilla G, Huseyinov A (2004) Gingival crevicular fluid monocyte chemoattractant protein-1 and RANTES levels in patients with generalized aggressive periodontitis. J Clin Periodontol 31(10):829–834. doi:10.1111/j.1600-051X.2004.00584.x
Kurtis B, Tuter G, Serdar M, Akdemir P, Uygur C, Firatli E, Bal B (2005) Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in patients with chronic and aggressive periodontitis. J Periodontol 76(11):1849–1855. doi:10.1902/jop.2005.76.11.1849
Cook DN (1996) The role of MIP-1 alpha in inflammation and hematopoiesis. J Leukoc Biol 59(1):61–66
Roth SJ, Carr MW, Springer TA (1995) C-C chemokines, but not the C-X-C chemokines interleukin-8 and interferon-gamma inducible protein-10, stimulate transendothelial chemotaxis of T lymphocytes. Eur J Immunol 25(12):3482–3488. doi:10.1002/eji.1830251241
Schall TJ, Bacon K, Camp RD, Kaspari JW, Goeddel DV (1993) Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes. J Exp Med 177(6):1821–1826
Taub DD, Conlon K, Lloyd AR, Oppenheim JJ, Kelvin DJ (1993) Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta. Science 260(5106):355–358
Garlet GP, Martins W Jr, Ferreira BR, Milanezi CM, Silva JS (2003) Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease. J Periodontal Res 38(2):210–217
Emingil G, Atilla G, Baskesen A, Berdeli A (2005) Gingival crevicular fluid EMAP-II, MIP-1alpha and MIP-1beta levels of patients with periodontal disease. J Clin Periodontol 32(8):880–885. doi:10.1111/j.1600-051X.2005.00780.x
Bischoff SC, Krieger M, Brunner T, Rot A, von Tscharner V, Baggiolini M, Dahinden CA (1993) RANTES and related chemokines activate human basophil granulocytes through different G protein-coupled receptors. Eur J Immunol 23(3):761–767. doi:10.1002/eji.1830230329
Emingil G, Gurkan A, Atilla G, Kantarci A (2011) Subantimicrobial-dose doxycycline and cytokine-chemokine levels in gingival crevicular fluid. J Periodontol 82(3):452–461. doi:10.1902/jop.2010.100036
Gemmell E, Carter CL, Seymour GJ (2001) Chemokines in human periodontal disease tissues. Clin Exp Immunol 125(1):134–141
Bergstrom J, Preber H (1994) Tobacco use as a risk factor. J Periodontol 65(5 Suppl):545–550. doi:10.1902/jop.1994.65.5s.545
Grossi SG, Genco RJ, Machtei EE, Ho AW, Koch G, Dunford R, Zambon JJ, Hausmann E (1995) Assessment of risk for periodontal disease. II. Risk indicators for alveolar bone loss. J Periodontol 66(1):23–29. doi:10.1902/jop.1995.66.1.23
Syrjala AM, Ylostalo P, Niskanen MC, Knuuttila ML (2003) Role of smoking and HbA1c level in periodontitis among insulin-dependent diabetic patients. J Clin Periodontol 30(10):871–875
Meisel P, Schwahn C, Gesch D, Bernhardt O, John U, Kocher T (2004) Dose-effect relation of smoking and the interleukin-1 gene polymorphism in periodontal disease. J Periodontol 75(2):236–242. doi:10.1902/jop.2004.75.2.236
Papapanou PN (1996) Periodontal diseases: epidemiology. Ann Periodontol 1(1):1–36. doi:10.1902/annals.1996.1.1.1
Rezavandi K, Palmer RM, Odell EW, Scott DA, Wilson RF (2002) Expression of ICAM-1 and E-selectin in gingival tissues of smokers and non-smokers with periodontitis. J Oral Pathol Med 31(1):59–64
Mirbod SM, Ahing SI, Pruthi VK (2001) Immunohistochemical study of vestibular gingival blood vessel density and internal circumference in smokers and non-smokers. J Periodontol 72(10):1318–1323. doi:10.1902/jop.2001.72.10.1318
Seow WK, Thong YH, Nelson RD, MacFarlane GD, Herzberg MC (1994) Nicotine-induced release of elastase and eicosanoids by human neutrophils. Inflammation 18(2):119–127
Haffajee AD, Socransky SS (2001) Relationship of cigarette smoking to the subgingival microbiota. J Clin Periodontol 28(5):377–388
van Winkelhoff AJ, Bosch-Tijhof CJ, Winkel EG, van der Reijden WA (2001) Smoking affects the subgingival microflora in periodontitis. J Periodontol 72(5):666–671. doi:10.1902/jop.2001.72.5.666
Gamal AY, Bayomy MM (2002) Effect of cigarette smoking on human PDL fibroblasts attachment to periodontally involved root surfaces in vitro. J Clin Periodontol 29(8):763–770
Ryder MI (2007) The influence of smoking on host responses in periodontal infections. Periodontol 2000 43:267–277. doi:10.1111/j.1600-0757.2006.00163.x
Walter C, Kaye EK, Dietrich T (2012) Active and passive smoking: assessment issues in periodontal research. Periodontol 2000 58(1):84–92. doi:10.1111/j.1600-0757.2011.00417.x
Warnakulasuriya S, Dietrich T, Bornstein MM, Casals Peidro E, Preshaw PM, Walter C, Wennstrom JL, Bergstrom J (2010) Oral health risks of tobacco use and effects of cessation. Int Dent J 60(1):7–30
Johnson JD, Houchens DP, Kluwe WM, Craig DK, Fisher GL (1990) Effects of mainstream and environmental tobacco smoke on the immune system in animals and humans: a review. Crit Rev Toxicol 20(5):369–395. doi:10.3109/10408449009089870
Loe H, Silness J (1963) Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 21:533–551
Lamster IB, Hartley LJ, Oshrain RL, Gordon JM (1985) Evaluation and modification of spectrophotometric procedures for analysis of lactate dehydrogenase, beta-glucuronidase and arylsulphatase in human gingival crevicular fluid collected with filter-paper strips. Arch Oral Biol 30(3):235–242
Gamonal J, Bascones A, Jorge O, Silva A (2000) Chemokine RANTES in gingival crevicular fluid of adult patients with periodontitis. J Clin Periodontol 27(9):675–681
Lamster IB, Oshrain RL, Fiorello LA, Celenti RS, Gordon JM (1988) A comparison of 4 methods of data presentation for lysosomal enzyme activity in gingival crevicular fluid. J Clin Periodontol 15(6):347–352
Lamster IB, Oshrain RL, Gordon JM (1986) Enzyme activity in human gingival crevicular fluid: considerations in data reporting based on analysis of individual crevicular sites. J Clin Periodontol 13(8):799–804
Griffiths GS, Wilton JM, Curtis MA (1997) Permeability of the gingival tissues to IgM during an experimental gingivitis study in man. Arch Oral Biol 42(2):129–136
Tymkiw KD, Thunell DH, Johnson GK, Joly S, Burnell KK, Cavanaugh JE, Brogden KA, Guthmiller JM (2011) Influence of smoking on gingival crevicular fluid cytokines in severe chronic periodontitis. J Clin Periodontol 38(3):219–228. doi:10.1111/j.1600-051X.2010.01684.x
Shimada Y, Tabeta K, Sugita N, Yoshie H (2013) Profiling biomarkers in gingival crevicular fluid using multiplex bead immunoassay. Arch Oral Biol 58(6):724–730. doi:10.1016/j.archoralbio.2012.11.012
Hanioka T, Takaya K, Matsumori Y, Matsuse R, Shizukuishi S (2000) Relationship of the substance P to indicators of host response in human gingival crevicular fluid. J Clin Periodontol 27(4):262–266
Lee E, Yang YH, Ho YP, Ho KY, Tsai CC (2003) Potential role of vascular endothelial growth factor, interleukin-8 and monocyte chemoattractant protein-1 in periodontal diseases. Kaohsiung J Med Sci 19(8):406–415. doi:10.1016/S1607-551X(09)70484-X
Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A (2000) Levels of interleukin-1 beta, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment. J Periodontol 71(10):1535–1545. doi:10.1902/jop.2000.71.10.1535
Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A (2001) Characterization of cellular infiltrate, detection of chemokine receptor CCR5 and interleukin-8 and RANTES chemokines in adult periodontitis. J Periodontal Res 36(3):194–203
Gemmell E, Seymour GJ (1998) Cytokine profiles of cells extracted from humans with periodontal diseases. J Dent Res 77(1):16–26
Anil S, Preethanath RS, Alasqah M, Mokeem SA, Anand PS (2013) Increased levels of serum and gingival crevicular fluid monocyte chemoattractant protein-1 in smokers with periodontitis. J Periodontol 84(9):e23–e28. doi:10.1902/jop.2013.120666
Pradeep AR, Daisy H, Hadge P (2009) Serum levels of monocyte chemoattractant protein-1 in periodontal health and disease. Cytokine 47(2):77–81. doi:10.1016/j.cyto.2009.05.012
Browne RW, Kantarci A, LaMonte MJ, Andrews CA, Hovey KM, Falkner KL, Cekici A, Stephens D, Genco RJ, Scannapieco FA, Van Dyke TE, Wactawski-Wende J (2013) Performance of multiplex cytokine assays in serum and saliva among community-dwelling postmenopausal women. PLoS One 8(4):e59498. doi:10.1371/journal.pone.0059498
Goodson JM, Kantarci A, Hartman ML, Denis GV, Stephens D, Hasturk H, Yaskell T, Vargas J, Wang X, Cugini M, Barake R, Alsmadi O, Al-Mutawa S, Ariga J, Soparkar P, Behbehani J, Behbehani K, Welty F (2014) Metabolic disease risk in children by salivary biomarker analysis. PLoS One 9(6):e98799. doi:10.1371/journal.pone.0098799
Acknowledgments
This study was supported by the Department of Scientific Research Projects (Project number 2216), Istanbul University.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Haytural, O., Yaman, D., Ural, E.C. et al. Impact of periodontitis on chemokines in smokers. Clin Oral Invest 19, 979–986 (2015). https://doi.org/10.1007/s00784-014-1314-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00784-014-1314-2